In July 2009, the ELITech Group, a French privately held group of companies and worldwide manufacturer and distributor of in-vitro diagnostic instruments and reagents finalized the acquisition of Nanogen’s two primary businesses: Epoch Biosciences located in Bothell, Washington and Nanogen Advanced Diagnostics with facilities located in Milan and Turin, Italy.
The ELITech Group is committed to the molecular diagnostics business to become a leading provider bringing high-value molecular diagnostics solutions to laboratories operating closer to the patient. With the introduction of the new brand ELITech Molecular Diagnostics, the Group intends to develop innovative, high-quality products allowing faster and easier diagnosis, treatment and monitoring of infectious diseases, oncology and hematology conditions.
Leveraging Nanogen’s industry-leading diagnostic tools, ELITech Molecular Diagnostics product offering includes tests for various DNA and RNA infectious diseases, genotyping tests for hematology and oncology targets. ELITech Molecular Diagnostics inherits from Nanogen a strong intellectual property portfolio and licensing program, which includes Minor Groove Binder (MGB) technology.
Headquartered in Paris, France, the Elitech Group has brought together IVD specialty companies to provide the best offering of innovative, unique and also routine products to laboratories. It comprises:
- Vital Scientific and Seppim which manufacture a full range of clinical chemistry analyzers and reagents;
- ELITech Microbio (former International Microbio) which manufactures microbiology kits;
- Wescor which manufactures unique laboratory instruments such as strainers and sweat test devices;
- inoDiag which manufactures a unique multiplex serology device;
- Nanogen which manufactures leading edge technology molecular biology kits.
Through direct sales in Europe and North America and distribution capabilities in over 100 countries, the ELITech Group offers clinical chemistry, microbiology, immunology and molecular biology products from its own facilities as well as complementary third-party products.